3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
1
Phase 1
1
Status
Completed
2
Sponsor Class
OTHER
4
NIH
2
NETWORK
2
OTHER_GOV
1
Study Type
Interventional
2
Sponsor
Cancer Type
Sarcoma
2
Conditions
Sarcoma
2
Triple Negative Breast Neoplasms
1
Rectal Neoplasms
1
Multiple Myeloma
1
Lymphoma, Non-Hodgkin
1
Colorectal Neoplasms
1
Colonic Neoplasms
1
Cholangiocarcinoma
1
Bone Neoplasms
1
Interventions
Ifosfamide
19
Doxorubicin
19
Filgrastim
17
Radiotherapy
13
Vincristine
11
Cyclophosphamide
11
Etoposide
9
Cisplatin
9
Granulocyte Colony-Stimulating Factor
8
Gene Expression Profiling
8
Trabectedin
7
Polymerase Chain Reaction
7
Dactinomycin
6
sargramostim
5
etoposide phosphate
5
Paclitaxel
5
Mesna
5
Chemotherapy, Adjuvant
4
Brachytherapy
4
pegfilgrastim
3
Topotecan
3
Microarray Analysis
3
Irinotecan
3
Immunohistochemistry
3
Imatinib Mesylate
3
Gemcitabine
3
Dexrazoxane
3
Base Sequence
3
olaparib
2
brostallicin
2
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
NETWORK
×
Sarcoma
×
olaparib
×
Clear all
NCT03838744
2024-12-04
TOMAS2
Italian Sarcoma Group
Phase 2
Completed
130 enrolled
NCT02398058
2021-04-14
TOMAS
Italian Sarcoma Group
Phase 1
Completed
50 enrolled